AMGN Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Amgen Inc. Stock Analysis AMGN
United States Health Care Large Cap Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 28,000 full-time employees. The company discovers, develops, manufactures and delivers medicines for the toughest diseases. The company focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. The company operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. The company markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. The company markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. The company markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.
Read More AMGN Chart
Amgen Inc vs S&P 500 Comparative Returns
Analysis of AMGN stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Amgen Inc (AMGN) 4.38%
- S&P 500 -4.27%
Amgen Inc Outperformed S&P 500 by 8.65%
1Y Performance
- Amgen Inc (AMGN) -11.47%
- S&P 500 8.86%
Amgen Inc Underperformed S&P 500 by 20.33%
3Y Performance
- Amgen Inc (AMGN) 13.71%
- S&P 500 37.21%
Amgen Inc Underperformed S&P 500 by 23.50%
5Y Performance
- Amgen Inc (AMGN) 15.85%
- S&P 500 92.3%
Amgen Inc Underperformed S&P 500 by 76.45%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$270.66Volume
3.62MP/E Ratio (TTM)
36.3152 Week Range
Market Cap
168.89BAvg. Volume
3.06MDividend Yield
3.25%Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 43.99 | 46.56 | 49.29 | 52.65 | - |
EBIT per Share (TTM) | 15.81 | 16.39 | 18.98 | 15.25 | - |
Earnings per Share (EPS) (TTM) | - | 10.34 | 12.18 | 12.56 | - |
Dividend per Share (TTM) | 6.5 | 7.19 | 7.86 | 8.51 | - |
EPS Forward | - | - | 12.11 | 12.49 | 7.56 |
Super Investors
View All ➜Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Cathie Wood
% Portfolio:
0.14 Recent Activity:-13.37%
Joel Greenblatt
% Portfolio:
0.05 Recent Activity:1.56%
Ken Fisher
% Portfolio:
0.04 Recent Activity:285.42%
Keeley-Teton Advisors, LLC
% Portfolio:
0.03 Recent Activity:-
Community-Curated Collections ( With AMGN )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
